Advaxis Stock Price - ADXS

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Advaxis Inc ADXS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.5378 0.00 0.00 0.00 0.5378 04:12:11
Bid Price Ask Price Spread Spread % News
0.539 0.56 0.021 3.75% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.5378 USD

Advaxis Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 32.40M 60.25M $ -66.52M 0.02 - 55.84M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -3.00 7.30%

more financials information »

Advaxis News

Loading Messages....

Latest ADXS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADXS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.5550.56790.5110.5292019807,298-0.0172-3.1%
1 Month0.740.810.410.57501371,527,040-0.2022-27.32%
3 Months1.251.350.410.91530824,328,012-0.7122-56.98%
6 Months0.35651.570.26250.73272956,717,7930.181350.86%
1 Year3.854.210.2020.68882594,303,851-3.31-86.03%
3 Years7.8410.800.1811.252,058,268-7.30-93.14%
5 Years15.9830.130.1814.221,640,224-15.44-96.63%

Advaxis Description

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.